Farther Finance Advisors, LLC Ascendis Pharma A/S Transaction History
Farther Finance Advisors, LLC
- $5 Trillion
- Q2 2025
A detailed history of Farther Finance Advisors, LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 222 shares of ASND stock, worth $43,458. This represents 0.0% of its overall portfolio holdings.
Number of Shares
222
Previous 166
33.73%
Holding current value
$43,458
Previous $25.1 Million
52.43%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ASND
# of Institutions
282Shares Held
62MCall Options Held
201KPut Options Held
226K-
Ra Capital Management, L.P. Boston, MA10.3MShares$2.01 Billion33.28% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.48MShares$1.07 Billion4.42% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.22MShares$1.02 Billion13.16% of portfolio
-
Janus Henderson Group PLC London, X04.49MShares$878 Million0.4% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.26MShares$833 Million1.14% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $10.9B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...